AMWL

In the past six months, American Well Corp. stock has declined by 17.41%, but has increased by 61.8% since the start of 2026, trading at $7.9350 as of May 9, 2026. The stock has traded between $3.71 and $9.15 over the past 52 weeks. Recent events include the Q1 2026 earnings report, which highlighted progress toward profitability despite an 18% year-over-year revenue decrease to $54.9 million. The company reported a reduced net loss of $10.3 million and an improved adjusted EBITDA loss of $3.1 million. Amwell reaffirmed its full-year 2026 revenue guidance of $195 million to $205 million and improved its adjusted EBITDA loss expectations to a range of $16 million to $12 million, with a target of achieving positive cash flow from operations in Q4 2026. The divestiture of Amwell Psychiatric Care in 2025 also impacted revenue guidance.